Cholinesterase inhibitors, NMDA-receptor antagonists, and their combination therapy, which makes up the currently approved medication, only temporarily relieve symptoms. Researchers from all over the world have made sincere attempts to find new targets, learn about, and create novel therapeutic molecules to relieve the symptoms of AD. Here, BCHE is linked to Alzheimer disease.